Global Leukemia Therapeutics Market Report By Therapy (Chemotherapy, Biological Therapy, Radiation Therapy, Targeted Therapy, And Other), Type (Chronic Leukemia, Chronic Lymphatic Leukemia, Chronic Myeloid Leukemia, Acute Leukemia, Acute Lymphatic Leukemia, Acute Myeloid Leukemia, And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026
ID:VMR11210140
January 2020
Report Formats:

Increased prevalence of cancer especially blood cancer across the world leading to rising demand for effective treatments is the driving market growth. Rise in expenditure on development of novel treatment and developing health infrastructure is further fueling the market growth. Additionally, the rise in survival rate and minimum side effects of novel treatment such as stem cell therapy, bone marrow transplant has open new avenues for the market growth. Furthermore, increasingly exposed to chemical mutation, changing dietary habits and living style of the population is further pushing the market growth.

The latest report by Value Market Research expects the Global Leukemia Therapeutics Market accounted for USD 10 billion and is expected to reach USD 12.5 billion at CAGR of 4% from the year 2017 to 2024.
 
ACUTE LEUKEMIA EMERGED AS THE LEADING THE SEGMENT
In 2017, acute leukemia is dominating the segment and has accounted for maximum market share. Owing to the growing condition of cancerous cells, acute leukemia is driving the segment growth. Rising smoking habits, exposure to chemicals, radiations and cases with other blood-related disorders are again fueling the segment growth.
 
CHEMOTHERAPY DOMINATED THE SEGMENT
By therapy, chemotherapy led the segment in 2017. Owing to an ability to kill cancerous cells or inhibiting its proliferation and maintain a normal level of lymphocytes of chemotherapy, it is driving the market growth. Also, the increased survival rate of the patients treated with chemotherapy is again fueling its demand.
 
NORTH AMERICA LED THE REGIONAL MARKET
Regionally, North America dominated the market by accounting major market share in 2017. Rise in the number of patients with cancer, growing genetic mutation, and increased expenditure has increased demand for effective treatment. This has driven the market growth from the last few years. Established healthcare infrastructure leading to the availability of advanced therapeutics has also contributed significantly to regional market growth.
 
KEY PLAYERS OF THE MARKET
AbbVie Inc., Amgen, ARIAD Pharmaceuticals, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline plc., Novartis International AG., Pfizer, and Teva Pharmaceuticals.  Companies are tending towards mergers and acquisition for development of novel therapeutics. For instance, TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform.

As per this study the Global Leukemia Therapeutics Market was valued USD XX BN (by revenue) in 2019 and is anticipated to reach USD XX BN by 2026 with a CAGR of X%.
 
Leukemia is a type of cancer that mainly developed into blood tissues and occur in bone marrow.  It developed gradually and leads to the uncontrolled growth of the blood cells. Leukemia is also termed as a cancer of white blood cells but also affect red blood cells and platelets. Fever, weight loss, night sweats, enlarged liver, frequent infections, and swollen lymph nodes are some of the common symptoms of leukemia. Leukemia therapeutic includes radiation, chemotherapy, and stem cell transplantation.
 
Market Dynamics
 
Rising cases of cancer worldwide along with the innovation in drug discovery and increasing investment in R&D sector is expected to fuel the industry expansion. Further, ongoing research in molecular diagnosis and rising government investment in the healthcare sector is another major factor serving as a key driver for the market. Also, stem cells and bone marrow transplant are the emerging trends observed in the leukemia therapeutic market and projected to propel the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of leukemia therapeutics.
 
Market Segmentation
 
The broad leukemia therapeutics market has been sub-grouped into therapy and type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Therapy

  • Chemotherapy
  • Biological Therapy
  • Radiation therapy
  • Targeted therapy
  • Other
 
By Type
  • Chronic leukemia
  • Chronic lymphatic leukemia
  • Chronic myeloid leukemia
  • Acute leukemia
  • Acute lymphatic leukemia
  • Acute myeloid leukemia
  • Others
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for leukemia therapeutics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Leukemia Therapeutics Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the leukemia therapeutics market includes AbbVie Inc., Amgen, ARIAD Pharmaceuticals, Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline plc., Novartis International AG., Pfizer, and Teva Pharmaceuticals. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Leukemia Therapeutics Market
       2.2. Global Leukemia Therapeutics Market Snapshot
 
3 . LEUKEMIA THERAPEUTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Leukemia Therapeutics Market
       3.3. Market Restraints of Leukemia Therapeutics Market
       3.4. Opportunities of Leukemia Therapeutics Market
       3.5. Trends of Leukemia Therapeutics Market
       3.6. Porter’s Five Force Analysis of Leukemia Therapeutics Market
       3.7. Leukemia Therapeutics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Therapy
           3.7.2 Market Attractive Analysis by Type
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Leukemia Therapeutics Value Chain Analysis
       4.2. Leukemia Therapeutics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Leukemia Therapeutics Raw Material Manufactures List
           4.2.3. Price Trend of Leukemia Therapeutics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL LEUKEMIA THERAPEUTICS MARKET ANALYSIS BY THERAPY
       5.1 Overview by Therapy
       5.2 Global Leukemia Therapeutics Market Analysis by Therapy
       5.3 Market Analysis of Chemotherapy by Regions
       5.4 Market Analysis of Biological Therapy by Regions
       5.5 Market Analysis of Radiation therapy by Regions
       5.6 Market Analysis of Targeted therapy by Regions
       5.7 Market Analysis of Other by Regions
 
6 . GLOBAL LEUKEMIA THERAPEUTICS MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Leukemia Therapeutics Market Analysis by Type
       6.3 Market Analysis of Chronic leukemia by Regions
       6.4 Market Analysis of Chronic lymphatic leukemia by Regions
       6.5 Market Analysis of Chronic myeloid leukemia by Regions
       6.6 Market Analysis of Acute leukemia by Regions
       6.7 Market Analysis of Acute lymphatic leukemia by Regions
       6.8 Market Analysis of Acute myeloid leukemia by Regions
       6.9 Market Analysis of Others by Regions
 
7 . GLOBAL LEUKEMIA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Leukemia Therapeutics Market Estimate by Market Segment
           7.3.3. North America Leukemia Therapeutics Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Leukemia Therapeutics Market Estimate by Market Segment
           7.4.3. Europe Leukemia Therapeutics Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Leukemia Therapeutics Market Estimate by Market Segment
           7.5.3. Asia Pacific Leukemia Therapeutics Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Leukemia Therapeutics Market Estimate by Market Segment
           7.6.3. Latin America Leukemia Therapeutics Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Leukemia Therapeutics Market Estimate by Market Segment
           7.7.3. Middle East & Africa Leukemia Therapeutics Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE LEUKEMIA THERAPEUTICS COMPANIES
       8.1. Leukemia Therapeutics Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF LEUKEMIA THERAPEUTICS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. AbbVie Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Amgen
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. ARIAD Pharmaceuticals, Inc.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Bristol-Myers Squibb
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. F. Hoffmann-La Roche Ltd.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Genzyme Corporation
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. GlaxoSmithKline Plc
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Novartis International AG.
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Pfizer
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Teva Pharmaceuticals
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES

  •  Global Leukemia Therapeutics Market Snapshot
  •  Drivers of The Global Leukemia Therapeutics Market Impact Analysis
  •  Restraints of The Global Leukemia Therapeutics Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Global Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chemotherapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Biological Therapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Radiation therapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Targeted therapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Other by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis by Type (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chronic leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chronic lymphatic leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chronic myeloid leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Acute leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Acute lymphatic leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Acute myeloid leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Others by Geography (USD MN)
  •  Global Leukemia Therapeutics Market by Geography (USD MN)
  •  North America Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  North America Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  North America Leukemia Therapeutics Market Estimate by Country (USD MN)
  •  United State Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  United State Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Rest of North America Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Rest of North America Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Europe Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Europe Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  United Kingdom Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  United Kingdom Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  France Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  France Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Germany Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Germany Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Rest of Europe Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Rest of Europe Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Asia Pacific Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Asia Pacific Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Asia Pacific Leukemia Therapeutics Market Estimate by Country (USD MN)
  •  China Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  China Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Japan Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Japan Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  India Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  India Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Rest of Asia Pacific Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Rest of Asia Pacific Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Latin America Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Latin America Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Latin America Leukemia Therapeutics Market Estimate by Country (USD MN)
  •  Brazil Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Brazil Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Rest of Latin America Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Rest of Latin America Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Middle East & Africa Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Middle East & Africa Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Middle East & Africa Leukemia Therapeutics Market Estimate by Country (USD MN)
  •  Middle East Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Middle East Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Africa Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Africa Leukemia Therapeutics Market Estimate by Type (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  •  Research Scope of Leukemia Therapeutics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Leukemia Therapeutics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Therapy
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Leukemia Therapeutics Market Analysis by Therapy (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chemotherapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Biological Therapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Radiation therapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Targeted therapy by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Other by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis by Type (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chronic leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chronic lymphatic leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Chronic myeloid leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Acute leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Acute lymphatic leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Acute myeloid leukemia by Geography (USD MN)
  •  Global Leukemia Therapeutics Market Analysis in Others by Geography (USD MN)
  •  Latin America Leukemia Therapeutics Market by Revenue
  •  Middle East & Africa Leukemia Therapeutics Market by Revenue
  •  Recent Development in Leukemia Therapeutics Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials